Aug 2026· Journal of Cystic Fibrosis· 0 citations· 20 references
Medicine
TL;DR
Altered muscle performance cannot be explained solely by muscle deconditioning and lower muscle size, suggesting intrinsic muscle alterations, and support the need for comprehensive assessment of peripheral muscle function and the continued prioritisation of interventions aiming to optimise muscle health.
Abstract
Background
Peripheral muscle dysfunction is a well-established extrapulmonary manifestation of cystic fibrosis (CF), contributing to exercise intolerance and reduced quality of life. However, its persistence in the era of highly effective CFTR modulator therapy (HEMT) remains unclear.
Methods
Fifty-six people with CF (age: 31 ± 13 years, BMI: 22 [20-24] kg·m-2; FEV1%: 77 ± 24; 95% treated with elexacaftor/tezacaftor/ivacaftor for 31 ± 11 months) were compared with 46 healthy controls of comparable age and sex distribution. Muscle function was assessed following international recommendations, including quadriceps strength (primary outcome), endurance and thickness, handgrip strength, and squat jump performance. Physical activity was assessed using accelerometry.
Results
Compared with controls, people with CF exhibited lower quadriceps strength (203 [161-304] vs. 284 [238-335] N·m, p = 0.001, rrb = 0.35) and endurance (p < 0.001, rrb = 0.47). Quadriceps thickness (p = 0.002, rrb = 0.34) and handgrip strength (p = 0.009, d = 0.48) were also lower. After normalisation to muscle thickness, quadriceps strength remained lower (p = 0.01, rrb = 0.27), whereas habitual physical activity levels did not differ significantly between groups.
Conclusion
This is the first large controlled study to comprehensively assess peripheral muscle function in people with CF following long-term HEMT exposure. Despite this prolonged exposure, clinically relevant impairments remained evident across multiple dimensions of muscle function. Altered muscle performance cannot be explained solely by muscle deconditioning and lower muscle size, suggesting intrinsic muscle alterations. These findings support the need for comprehensive assessment of peripheral muscle function and the continued prioritisation of interventions aiming to optimise muscle health.
OBJECTIVES
Highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators (HEMTs) have significantly improved outcomes in people with cystic fibrosis (CF). Their impact on established pancreatic disease remains uncertain. We aimed to evaluate the effects of HEMTs on exocrine pancreatic function...
R. Cerchione, A. Tosco, C. Cimbalo et al.· Journal of Pediatric Gastroe...· 0 citations
U-titin levels increased during empagliflozin treatment, suggesting a possible association with skeletal muscle degradation, and seem to reflect nutritional and functional status in patients with heart failure.
T. Nishikawa, N. Nakanishi, K. Osawa et al.· BMC Cardiovascular Disorders· 0 citations
The clinical response to elexacaftor/tezacaftor/ivacaftor (ETI) in people with cystic fibrosis carrying the rare cystic fibrosis transmembrane conductance regulator (CFTR) variant W1282R has not been well characterized. We retrospectively analyzed 12 people with cystic fibrosis treated with ETI for 3–36 months in addit...
E. Kondratyeva, A. Efremova, Y. Melyanovskaya et al.· International Journal of Mol...· 0 citations
Introduction.
Prior to recent years, treatment of cystic fibrosis (CF) consisted primarily of symptom management. The pathogenetic therapy with CFTR modulators has emerged as a revolutionary method, supplying the capacity to correct the underlying CFTR chloride channel dysfunction.
Aim.
To evaluate the effic...
E. Kondratyeva, A. Voronkova, E. Zhekayte et al.· Meditsinskiy sovet = Medical...· 0 citations
Sarcopenia is common in patients of chronic pancreatitis, and it is characterized by activation of catabolic signaling, impaired anabolic pathways, mitochondrial dysfunction, and defective autophagy, and these findings are hypothesis-generating and may help identify targets to mitigate muscle loss and improve outcomes.
N. Lohani, Sumaira Qamar, Deepika Verma et al.· Pancreatology : official jou...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.